These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 31583380)

  • 21. Pharmacologic Approaches to Weight Management: Recent Gains and Shortfalls in Combating Obesity.
    Saunders KH; Kumar RB; Igel LI; Aronne LJ
    Curr Atheroscler Rep; 2016 Jul; 18(7):36. PubMed ID: 27181165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of obesity in 2015.
    Shukla AP; Buniak WI; Aronne LJ
    J Cardiopulm Rehabil Prev; 2015; 35(2):81-92. PubMed ID: 25714749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current and Emerging Pharmacotherapies for Weight Management in Prediabetes and Diabetes.
    Lau DC; Teoh H
    Can J Diabetes; 2015 Dec; 39 Suppl 5():S134-41. PubMed ID: 26654857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Challenging obesity, diabetes, and addiction: the potential of lorcaserin extended release.
    Hurt RT; Mundi MS; Ebbert JO
    Diabetes Metab Syndr Obes; 2018; 11():469-478. PubMed ID: 30233224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Obesity management among patients with type 2 diabetes and prediabetes: a focus on lifestyle modifications and evidence of antiobesity medications.
    Nguyen B; Clements J
    Expert Rev Endocrinol Metab; 2017 Sep; 12(5):303-313. PubMed ID: 30058889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term pharmacotherapy for obesity and overweight.
    Padwal R; Li SK; Lau DC
    Cochrane Database Syst Rev; 2003; (4):CD004094. PubMed ID: 14584004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liraglutide: A Glucagon-Like Peptide-1 Agonist for Chronic Weight Management.
    Manigault KR; Thurston MM
    Consult Pharm; 2016 Dec; 31(12):685-697. PubMed ID: 28074747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacotherapy for Obesity.
    Saunders KH; Shukla AP; Igel LI; Kumar RB; Aronne LJ
    Endocrinol Metab Clin North Am; 2016 Sep; 45(3):521-38. PubMed ID: 27519128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Update on Office-Based Strategies for the Management of Obesity.
    Erlandson M; Ivey LC; Seikel K
    Am Fam Physician; 2016 Sep; 94(5):361-8. PubMed ID: 27583422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacotherapy for the management of obesity.
    Patel D
    Metabolism; 2015 Nov; 64(11):1376-85. PubMed ID: 26342499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Formulary management of 2 new agents: lorcaserin and phentermine/topiramate for weight loss.
    Kelly EM; Tungol AA; Wesolowicz LA
    J Manag Care Pharm; 2013 Oct; 19(8):642-54. PubMed ID: 24074010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ; Bailey CJ
    Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Review of pharmacotherapy options for the management of obesity.
    Bragg R; Crannage E
    J Am Assoc Nurse Pract; 2016 Feb; 28(2):107-15. PubMed ID: 26119641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The safety and efficacy of lorcaserin in the management of obesity.
    Hess R; Cross LB
    Postgrad Med; 2013 Nov; 125(6):62-72. PubMed ID: 24200762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liraglutide, GLP-1 receptor agonist, for chronic weight loss.
    Moore KG; Shealy K; Clements JN
    Expert Rev Endocrinol Metab; 2016 Sep; 11(5):373-378. PubMed ID: 30058906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can we win the war on obesity with pharmacotherapy?
    Gotthardt JD; Bello NT
    Expert Rev Clin Pharmacol; 2016 Oct; 9(10):1289-1297. PubMed ID: 27590007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiobesity pharmacotherapy for patients with type 2 diabetes: focus on long-term management.
    Jeon WS; Park CY
    Endocrinol Metab (Seoul); 2014 Dec; 29(4):410-7. PubMed ID: 25559569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of antiobesity medications in patients with type 2 diabetes mellitus.
    Choussein S; Makri AA; Frangos CC; Petridou ET; Daskalopoulou SS
    Diabetes Obes Metab; 2009 Jul; 11(7):641-64. PubMed ID: 19236442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medication use for the treatment of diabetes in obese individuals.
    Wilding JPH
    Diabetologia; 2018 Feb; 61(2):265-272. PubMed ID: 28501906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New obesity agents: lorcaserin and phentermine/topiramate.
    Fleming JW; McClendon KS; Riche DM
    Ann Pharmacother; 2013; 47(7-8):1007-16. PubMed ID: 23800750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.